Literature DB >> 21935743

Reversible blocking of amino groups of octreotide for the inhibition of formation of acylated peptide impurities in poly(lactide-co-glycolide) delivery systems.

Jae Hwa Ahn1, Eun Ji Park, Hye Suk Lee, Kang Choon Lee, Dong Hee Na.   

Abstract

The purpose of this study was to develop a novel method to inhibit the formation of acylated peptide impurities in poly(D,L-lactide-co-glycolide) (PLGA) formulations by reversely blocking the amino groups of octreotide with maleic anhydride (MA). Two mono-MA conjugates with different modification sites (N terminus and Lys residue) and di-MA conjugate of octreotide were prepared and isolated by reversed-phase high-performance liquid chromatography (RP-HPLC). The polymer interaction of peptides and the formation of acylated peptides were monitored by RP-HPLC. The stability of MA-octreotide conjugates in PLGA films was studied in 0.1 M phosphate buffer (pH 7.4) at 37°C. The conjugation of MA to octreotide substantially inhibited the interaction of peptide with PLGA polymer and the subsequent formation of acylated peptide impurities. The MA-octreotides were successfully converted to intact octreotide as pH drops by PLGA hydrolysis. In PLGA films, MA-octreotide also showed complete inhibition of peptide acylation. In conclusion, MA conjugation provides a viable approach for stabilizing peptides in PLGA delivery systems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21935743      PMCID: PMC3225552          DOI: 10.1208/s12249-011-9694-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  25 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.

Authors:  Dong Hee Na; Yu Seok Youn; Sang Deuk Lee; Mi-Won Son; Won-Bae Kim; Patrick P DeLuca; Kang Choon Lee
Journal:  J Control Release       Date:  2003-10-30       Impact factor: 9.776

Review 3.  Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.

Authors:  Ugo Bilati; Eric Allémann; Eric Doelker
Journal:  Eur J Pharm Biopharm       Date:  2005-04       Impact factor: 5.571

4.  Peptide acylation by poly(alpha-hydroxy esters).

Authors:  Andrea Lucke; Josef Kiermaier; Achim Göpferich
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

Review 5.  Octreotide.

Authors:  S W Lamberts; A J van der Lely; W W de Herder; L J Hofland
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

6.  Impurity formation studies with peptide-loaded polymeric microspheres Part I. In vivo evaluation.

Authors:  Santos B Murty; B C Thanoo; Qui Wei; Patrick P DeLuca
Journal:  Int J Pharm       Date:  2005-06-13       Impact factor: 5.875

7.  The effect of poly(ethylene glycol)-poly(D,L-lactic acid) diblock copolymers on peptide acylation.

Authors:  Andrea Lucke; Elisabetta Fustella; Jörg Tessmar; Andrea Gazzaniga; Achim Göpferich
Journal:  J Control Release       Date:  2002-04-23       Impact factor: 9.776

Review 8.  Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms.

Authors:  M L Houchin; E M Topp
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

9.  Mechanisms of action of long-acting analogs of somatostatin.

Authors:  F Chen; M S O'Dorisio; G Hermann; J Hayes; W B Malarkey; T M O'Dorisio
Journal:  Regul Pept       Date:  1993-04-08

10.  Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity.

Authors:  Dong Hee Na; Jeong Eun Lee; Sun Woo Jang; Kang Choon Lee
Journal:  AAPS PharmSciTech       Date:  2007-06-08       Impact factor: 3.246

View more
  5 in total

1.  Comparative studies on the influences of primary emulsion preparation on properties of uniform-sized exenatide-loaded PLGA microspheres.

Authors:  Feng Qi; Jie Wu; Dongxia Hao; Tingyuan Yang; Yu Ren; Guanghui Ma; Zhiguo Su
Journal:  Pharm Res       Date:  2014-01-08       Impact factor: 4.200

2.  Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.

Authors:  Ravi D Vaishya; Abhirup Mandal; Mitan Gokulgandhi; Sulabh Patel; Ashim K Mitra
Journal:  Int J Pharm       Date:  2015-05-01       Impact factor: 5.875

3.  Proton Oriented-"Smart Depot" for Responsive Release of Ca2+ to Inhibit Peptide Acylation in PLGA Microspheres.

Authors:  Jiwei Liu; Yan Xu; Yonglu Wang; Hao Ren; Zhengjie Meng; Kuntang Liu; Zhe Liu; He Huang; Xueming Li
Journal:  Pharm Res       Date:  2019-06-04       Impact factor: 4.200

4.  Acylation of exenatide by glycolic acid and its anti-diabetic activities in db/db mice.

Authors:  Rongcai Liang; Xiang Li; Renyu Zhang; Yanan Shi; Aiping Wang; Daquan Chen; Kaoxiang Sun; Wanhui Liu; Youxin Li
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

5.  Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release.

Authors:  Ravi D Vaishya; Abhirup Mandal; Sulabh Patel; Ashim K Mitra
Journal:  Int J Pharm       Date:  2015-11-10       Impact factor: 5.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.